Marc-Antoine Benderra

Oncotype DX^® molecular signature: Focusing on premenopausal female patients and female patients over the age of 70

• By Marc-Antoine Benderra
• and Djamel Ghebriou

In Innovations & Thérapeutiques en Oncologie (2025/1 Volume 11)

Managing HER2-positive metastatic breast cancer

• By Marc-Antoine Benderra
• and Joseph Gligorov

In Innovations & Thérapeutiques en Oncologie (2024/N° Supp 2 Volume 10)

The latest French guidelines on the clinical utility of genomic tests for early-stage breast cancer:

Between recommendations and the real-life consideration of genomic signatures in breast cancer

• By Marc-Antoine Benderra
• and Xavier Barthere

In Innovations & Thérapeutiques en Oncologie (2024/3 Volume 10)